Autoren
Created byThiago Moulin
Attachments
Ereignisse
Pegaptanib safe/effectiveBOLT study:
More evidence on the
benefit of bevacizumabDRCR.net Protocol H:
Bevacizumab safe/effectiveDRCR.net Protocol I:
Ranibizumab better than
focal laser ± triamcinoloneRESTORE study:
Ranibizumab ± focal laser
better than focal laser aloneRISE/RIDE studies:
Phase III RCT for RanibizumabFDA approves
Ranibizumab for DMEDA VINCI study:
Aflibercept safe/effectiveVIVID/VISTA studies:
Phase III RCT for AfliberceptFDA approves
Aflibercept for DMEFDA approves
dexamethasone
implant for DMEFDA approves
0.19 mg fluocinolone
implant for DMEMEAD study:
Phase III RCT for
dexamethasone implantFAME study:
Phase III RCT for
0.19 fluocinolone
implant
Comments